DK132074B - Sulfaterede peptidamider eller deres pharmaceutisk acceptable salte til anvendelse som galdeblæresammentrækkende midler ved røntgendiagnostik af galdeblærelidelser. - Google Patents

Sulfaterede peptidamider eller deres pharmaceutisk acceptable salte til anvendelse som galdeblæresammentrækkende midler ved røntgendiagnostik af galdeblærelidelser.

Info

Publication number
DK132074B
DK132074B DK240169AA DK240169A DK132074B DK 132074 B DK132074 B DK 132074B DK 240169A A DK240169A A DK 240169AA DK 240169 A DK240169 A DK 240169A DK 132074 B DK132074 B DK 132074B
Authority
DK
Denmark
Prior art keywords
gallbladder
astringents
pharmaceutically acceptable
acceptable salts
ray diagnosis
Prior art date
Application number
DK240169AA
Other languages
English (en)
Other versions
DK132074C (da
Inventor
M A Ondetti
J Pluscec
J T Sheehan
J E Jorpes
V Mutt
Original Assignee
M A Ondetti
J Pluscec
J T Sheehan
J E Jorpes
V Mutt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M A Ondetti, J Pluscec, J T Sheehan, J E Jorpes, V Mutt filed Critical M A Ondetti
Publication of DK132074B publication Critical patent/DK132074B/da
Application granted granted Critical
Publication of DK132074C publication Critical patent/DK132074C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
DK240169A 1968-05-03 1969-05-01 Sulfaterede peptidamider eller deres pharmaceutisk acceptablesalte til anvendelse som galdebleresammentrekkende midler vedrontgendiagnostik af galdeblerelidelser DK132074C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00726558A US3839315A (en) 1968-05-03 1968-05-03 Novel peptides having cholecystokinin activity and intermediates therefor

Publications (2)

Publication Number Publication Date
DK132074B true DK132074B (da) 1975-10-20
DK132074C DK132074C (da) 1976-05-03

Family

ID=24919088

Family Applications (1)

Application Number Title Priority Date Filing Date
DK240169A DK132074C (da) 1968-05-03 1969-05-01 Sulfaterede peptidamider eller deres pharmaceutisk acceptablesalte til anvendelse som galdebleresammentrekkende midler vedrontgendiagnostik af galdeblerelidelser

Country Status (8)

Country Link
US (1) US3839315A (da)
JP (1) JPS4813114B1 (da)
CA (1) CA945145A (da)
CH (1) CH517702A (da)
DK (1) DK132074C (da)
FR (1) FR2007810B1 (da)
GB (2) GB1278681A (da)
SE (1) SE372007B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019115B1 (de) * 1979-04-30 1983-01-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Pankreozymin-Cholezystokinin aktive Peptide, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
US4610816A (en) * 1980-12-18 1986-09-09 Schering Corporation Substituted dipeptides as inhibitors of enkephalinases
US4906615A (en) * 1980-12-18 1990-03-06 Schering Corporation Substituted dipeptides as inhibitors of enkephalinases
US4444682A (en) * 1982-11-04 1984-04-24 The Salk Institute For Biological Studies Method of sulfation
US4769445A (en) * 1985-03-04 1988-09-06 Pennwalt Corporation Process for the solid phase synthesis of peptides which contain sulfated tyrosine
US5086042A (en) * 1985-12-19 1992-02-04 Fisons Corporation Peptides with sulfate ester groups
US4808701A (en) * 1987-03-30 1989-02-28 Hoffmann-La Roche Inc. Cyclic peptides having appetite regulating activity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472832A (en) * 1966-08-09 1969-10-14 Farmaceutici Italia Peptides related to caerulein
US3488726A (en) * 1967-07-31 1970-01-06 Squibb & Sons Inc R-l-methionyl-glycyl octapeptides related to caerulein and intermediates therefor
US3705140A (en) * 1967-10-05 1972-12-05 Luigi Bernardi Peptides related to the c-terminal sequence of cck-pz and caerulein
US3579494A (en) * 1968-07-18 1971-05-18 Squibb & Sons Inc C-sulfonated tyrosyl peptides related to cholecystokinin-pan-creozymin (cck-pz)

Also Published As

Publication number Publication date
DE1922185B2 (de) 1975-09-04
DE1922185A1 (de) 1969-11-20
FR2007810A1 (da) 1970-01-09
CH517702A (fr) 1972-01-15
JPS4813114B1 (da) 1973-04-25
SE372007B (da) 1974-12-09
FR2007810B1 (da) 1974-05-24
CA945145A (en) 1974-04-09
GB1278682A (en) 1972-06-21
GB1278681A (en) 1972-06-21
DK132074C (da) 1976-05-03
US3839315A (en) 1974-10-01

Similar Documents

Publication Publication Date Title
DK115631B (da) Fremgangsmåde til fremstilling af analgetisk og narkotisk antagonistisk virksomme derivater af 14-hydroxydihydronormorfin eller farmaceutisk acceptable salte deraf.
NO149139C (no) Dimetyloksofosfonater for anvendelse som utgangsmateriale ved fremstilling av fysiologisk aktive prostaglandiner
DK142948C (da) Analogifremgangsmaade til fremstilling af biphenylyl-acetylaminopyridiner eller fysiologisk acceptable salte heraf
DK132074B (da) Sulfaterede peptidamider eller deres pharmaceutisk acceptable salte til anvendelse som galdeblæresammentrækkende midler ved røntgendiagnostik af galdeblærelidelser.
DK124265B (da) Analogifremgangsmåde til fremstilling af cephalosporanderivater eller α-karbonylderivater eller salte deraf eller af α-karbonylderivaterne.
DK120954B (da) Jodholdige bezoesyrederivater eller salte deraf til anvendelse som røntgenkontrastmidler.
BR6804640D0 (pt) Composicao para limpeza de superficies duras
DK134647C (da) Analogifremgangsmade til fremstilling af cephalosporinderivater eller terapeutisk acceptable salte deraf
DK136115B (da) Ketaler af 3,5,17-trioxo-13beta-alkyl-4,5-secogonaner til anvendelse som mellemprodukter ved fremstillingen af 19-nor-steroider.
DK138638B (da) Indanderivater til anvendelse som mellemprodukter ved fremstilling af 19-nor-steroider.
DK125476B (da) N-(2-tetrahydrofuryl)-methylphtalimid til anvendelse som mellemprodukt ved fremstilling af 2-aminomethylpyrrolidiner.
DK119055B (da) Analogifremgangsmåde til fremstilling af benzensulfonylurinstoffer eller salte deraf.
DK112309B (da) Fremgangsmåde til fremstilling af benzensulfonylurinstoffer eller deres salte.
DK137857B (da) Analogifremgangsmåde til fremstilling af 2-amino-1,5-benzodiazocinderivater eller farmaceutisk acceptable salte deraf.
DK133299C (da) Analogifremgangsmade til fremstilling af 1,4-benzodiazepiner eller farmaceutisk acceptable salte heraf
DK126197B (da) 1-Formyl-3-nitro-azacycloalkan-2-oner til anvendelse som mellemprodukter ved fremstilling af N-substituerede aminoazacycloalkanoner eller aminosyrer.
DK126110B (da) Analogifremgangsmåde til fremstilling af benzensulfonylurinstoffer eller deres salte.
DK139265B (da) Analogifremgangsmåde til fremstilling af 1,2,4-oxadiazolforbindelser eller farmaceutisk acceptable salte deraf.
DK129414B (da) Analogifremgangsmåde til fremstilling af benzensulfonylurinstoffer eller fysiologisk uskadelige salte deraf med baser.
DK127974B (da) Analogifremgangsmåde til fremstilling af salte af N-[4-(β-<2-methoxy-5-chlor-benzamido>-ethyl)-benzensulfonyl]-N'-cyclohexyl- eller -cyclopentylurinstof med anionbyttere.
DK114627B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 3-aminoindazoler eller farmaceutisk acceptable salte deraf.
DK140762B (da) Analogifremgangsmaade til fremstilling af 7,8-dihydropteridiner eller tautomere eller salte deraf
DK133505B (da) Fremgangsmåde til fremstilling af benzazocinderivater eller farmaceutisk acceptable salte deraf.
ES166005Y (es) Cajon perfeccionado para casillero.
DK139578B (da) 5-Sulfamylbenzoesyrederivater eller salte eller estre deraf til anvendelse som mellemprodukt ved fremstilling af N-substituerede-2- eller 3-amino-5-sulfamylbenzoesyrederivater.

Legal Events

Date Code Title Description
PUP Patent expired